Generics BulletinFollowing years of development and setbacks, Cipla has won US Food and Drug Administration approval for a generic version of Bristol Myers Squibb’s hard-to-manufacture Abraxane (protein-bound paclitax
Pink SheetUS President Donald Trump has announced a general 26% reciprocal tariff on India, but a country-agnostic exemption of categories like pharmaceuticals implies that Indian pharma firms will not be direc
ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. Dr. Reddy’s Acquires Rights From
ScripEli Lilly’s blockbuster obesity and type 2 diabetes therapy, Mounjaro (tirzepatide) has made its India debut throwing down the gauntlet to rival Novo Nordisk, currently in the wings with Wegovy (injec